Featured
New Guidelines for Stroke Rehabilitation Released
Clinic Moves Aug 31, 2026
Trial Briefs Aug 30, 2026
Drug Approvals Aug 29, 2026
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with...
Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing...
FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam...
Read our latest Drug Approvals articles.
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify...
Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering...
Republican lawmakers vote to hold Fauci in contempt of Congress over COVID-19 pandemic handling disputes,...
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with updated recommendations.
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with updated recommendations.
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn how it tackles the root...
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify amyloid pathology in adults 55...
Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing a targeted alternative to systemic...
FDA approval of Avulux migraine lenses offers an over‑the‑counter solution to reduce photophobia for migraine sufferers aged 12+, complementing existing...
Gene therapy MPS II stalls as the FDA places a clinical hold on RGX-121 after MRI scans revealed spinal abnormalities,...
Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering better protection than aspirin or...
FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam drug application.
New phase 2 trial finds oral cannabis oil failed to reduce chronic pain in Parkinson patients. Read the latest analysis...
Researchers develop toolkit to address policymaking privilege disparities and inequities in public policy decisions.